Database of Monochorionic Pregnancies
Launched by UNIVERSITY OF MIAMI · Sep 14, 2022
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Database of Monochorionic Pregnancies, is studying pregnancies that involve twins sharing a placenta, known as monochorionic twins. These types of pregnancies can sometimes lead to complications, such as Twin to Twin Transfusion Syndrome (where one twin receives too much blood and the other too little). The main goal of this study is to gather and analyze information about how these pregnancies progress, the reasons for any medical interventions, and the health outcomes for both mothers and their babies.
To participate in this study, women must be 18 years or older and have been evaluated or treated for complications related to a monochorionic twin pregnancy at the University of Miami. If a woman decides not to participate or cannot be followed up after joining, she will not be included in the study. Those who join can expect to provide information about their health and their babies' health, which will help researchers understand these complex pregnancies better and improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The study population will consist of MC pregnancies (maternal, fetal, and neonatal data) that have undergone evaluation and/or treatment for complications attributable to monochorionic twin pregnancy at the University of Miami.
- • Maternal age 18 years and older.
- Exclusion Criteria:
- • Participation declined or consent not granted in prospective arm
- • Loss to follow-up
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Miami, Florida, United States
Patients applied
Trial Officials
Rodrigo Ruano, MD PhD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials